Crossmark

Tracking Anti- Staphylococcus aureus Antibodies Produced In Vivo and Ex Vivo during Foot Salvage Therapy for Diabetic Foot Infections Reveals Prognostic Insights and Evidence of Diversified Humoral Immunity

Crossref DOI link: https://doi.org/10.1128/IAI.00629-18

Published Print: 2018-12

Update policy: https://doi.org/10.1128/asmj-crossmark-policy-page

Authors

Oh, Irvin

Muthukrishnan, Gowrishankar https://orcid.org/0000-0001-7521-6154
Ninomiya, Mark J.

Brodell, James D. Jr.

Smith, Benjamin L.

Lee, Charles C.

Gill, Steven R.

Beck, Christopher A.

Schwarz, Edward M.

Daiss, John L.
Funding

Funding for this research was provided by:

HHS | NIH | National Institute of Allergy and Infectious Diseases (AI119646)

HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50AR072000)
License Information

Text and Data Mining valid from 2018-12-01
More Information

Publication History

Received: 2018-08-12

Accepted: 2018-09-20

Published: 2018-11-20

Document is current

Any future updates will be listed below